Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia
High-Dose Methotrexate in Acute Lymphoblastic Leukemia: Where Is the Evidence for Its Continued Use?
2005 ◽
Vol 25
(5)
◽
pp. 748-755
◽
2006 ◽
Vol 24
(6)
◽
pp. 785-791
◽
1996 ◽
Vol 13
(4)
◽
pp. 359-367
◽